3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
7
NETWORK
6
NIH
2
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
32
CNS
21
Lymphoid
8
Dermatologic
7
Genitourinary
6
Gastrointestinal
6
Endocrine
3
Thoracic
2
Other solid neoplasm
2
Head & Neck
2
Plasma cell
1
Other hematologic neoplasm
1
NET
1
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
1006
Uterine Cervical Neoplasms
420
Endometrial Neoplasms
350
Carcinoma, Non-Small-Cell Lung
292
Breast Neoplasms
292
Neoplasms
238
Colorectal Neoplasms
233
Fallopian Tube Neoplasms
211
Stomach Neoplasms
192
Pancreatic Neoplasms
184
Melanoma
157
Prostatic Neoplasms
152
Triple Negative Breast Neoplasms
148
Carcinoma, Ovarian Epithelial
147
Lung Neoplasms
136
Neoplasm Metastasis
133
Squamous Cell Carcinoma of Head and Neck
131
Carcinoma, Renal Cell
130
Head and Neck Neoplasms
122
Esophageal Neoplasms
121
Urinary Bladder Neoplasms
112
Small Cell Lung Carcinoma
90
Sarcoma
80
Carcinoma, Hepatocellular
76
Recurrence
70
Carcinoma, Transitional Cell
70
Uterine Cervical Dysplasia
66
Papillomavirus Infections
66
Colonic Neoplasms
59
Cholangiocarcinoma
59
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Rhabdomyosarcoma
×
Gynecologic
×
Clear all
NCT05697198
2025-03-06
PREFER
Labcorp Corporation of America Holdings, Inc
Completed
1,429 enrolled